As of Feb 27
| +0.09 / +3.45%|
The 1 analysts offering 12-month price forecasts for Clinuvel Pharmaceuticals Ltd have a median target of 3.24, with a high estimate of 3.24 and a low estimate of 3.24. The median estimate represents a +19.87% increase from the last price of 2.70.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.